Skip to main content
Caplight Logo









Oncobit

Oncobit

Private
SchlierenHealthcare & Life Scienceshttps://oncobit.com/en/

Last Round

Early Funding

Nov 27, 2025

Total Funding Raised

$6.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oncobit AG is a medtech company that has developed a scalable, data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers in liquid biopsies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

liquid biopsycancer monitoringctDNA analysisprecision oncologyAI diagnosticsdigital PCRdPCRcirculating tumor DNActDNAcancer monitoring platformclinical decision supporttreatment response monitoringmelanoma monitoringclinical trial supportIVDR certification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncobit Comparables

Compare Oncobit with similar companies based on industry and business-model similarity.

Oncobit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hedera Dx
87%
ID SOLUTIONS
77%
Sysmex Corporation
74%

Oncobit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 27, 2025
Early FundingNov 20, 2024
SeedApr 29, 2021

Key People

Founding team and executive leadership

Claudia Scheckel

Chief Executive Officer

Executive Team

Oncobit Investors

Notable investors and investment history

Oncobit investors
InvestorRounds
Avanteca PartnersSeed
ID SOLUTIONSEarly Funding
GF Group HoldingSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 105% MoM.

  • Nov 27, 2025

    Raised $2.36M with ID SOLUTIONS participating

Oncobit Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Oncobit Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oncobit's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range14
Year Founded2018
Last FundingNov 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?